Changes in cognitive appraisal in a randomized controlled trial of mindfulness-based cognitive therapy for patients with migraine

被引:4
|
作者
Kruse, Jessica A. [1 ,4 ]
Seng, Elizabeth K. [1 ,2 ,3 ]
机构
[1] Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY USA
[2] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY USA
[3] Montefiore Headache Ctr, Montefiore Med Ctr, Bronx, NY USA
[4] Yeshiva Univ, Ferkauf Grad Sch Psychol, 1165 Morris Pk Ave, Bronx, NY 10461 USA
来源
HEADACHE | 2023年 / 63卷 / 10期
关键词
metacognition; migraine; mindfulness; pain catastrophizing; BEHAVIORAL THERAPY; STRESS REDUCTION; CHRONIC PAIN; DISABILITY; FUSION; WOMEN; MODEL;
D O I
10.1111/head.14627
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveThis study is a secondary analysis evaluating changes in cognitive fusion and pain catastrophizing over 8 weeks of mindfulness-based cognitive therapy for migraine (MBCT-M) intervention versus waitlist/treatment as usual.BackgroundMigraine is a common disabling neurological condition. MBCT-M combines elements of cognitive behavioral therapy with mindfulness-based approaches and has demonstrated efficacy in reducing migraine-related disability.MethodsA total of 60 adults with migraine completed a 30-day run-in before randomization into a parallel design of either eight weekly individual MBCT-M sessions (n = 31) or waitlist/treatment as usual (n = 29): participants were followed for 1 month after. Participants completed the Pain Catastrophizing Scale (PCS) and the Cognitive Fusion Questionnaire (CFQ) at Months 0, 1, 2, and 4.ResultsThe PCS scores decreased more in the MBCT-M group (mean [SD] at baseline = 22.5 [9.6]; at Month 4 = 15.1 [8.8]) than in the waitlist/treatment as usual group (mean [SD] at baseline = 24.9 [9.0]; at Month 4 = 22.5 [10.4]) from Month 0 to 4 (beta = -7.24, p = 0.001, 95% confidence interval [CI] -11.39 to -3.09). The CFQ (mean [SD] baseline = 27.6 [8.0]; at Month 4 = 25.0 [8.0]) did not change significantly from Month 0 to 4 (beta = -1.2, p = 0.482, 95% CI -4.5 to 2.1). Parallel mediation analyses indicated that decreases in the PCS and CFQ together (beta = -6.1, SE = 2.5, 95% CI -11.6 to -1.8), and the PCS alone (beta = -4.8, SE = 2.04, 95% CI -9.1 to -1.1), mediated changes in headache disability in the MBCT-M treatment completer group (n = 19).ConclusionIn this study, pain catastrophizing showed strong promise as a potential mechanism of MBCT-M. Future research should continue to explore cognitive appraisal changes in mindfulness-based interventions.
引用
收藏
页码:1403 / 1411
页数:9
相关论文
共 50 条
  • [41] Review: randomized controlled trials of Mindfulness-Based Stress reduction and mindfulness based cognitive therapy
    Fjorback, L. O.
    Rehfeld, E.
    Schroder, A.
    Arendt, M.
    Fink, P.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2008, 64 (06) : 650 - 650
  • [42] Cognitive therapy, mindfulness-based stress reduction, and behavior therapy for the treatment of chronic pain: randomized controlled trial
    Burns, John W.
    Jensen, Mark P.
    Thorn, Beverly
    Lillis, Teresa A.
    Carmody, James
    Newman, Andrea K.
    Keefe, Francis
    PAIN, 2022, 163 (02) : 376 - 389
  • [43] A Randomized Controlled Trial on the Efficacy of Mindfulness-Based Cognitive Therapy and a Group Version of Cognitive Behavioral Analysis System of Psychotherapy for Chronically Depressed Patients
    Michalak, Johannes
    Schultze, Martin
    Heidenreich, Thomas
    Schramm, Elisabeth
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2015, 83 (05) : 951 - 963
  • [44] Effectiveness of mindfulness-based cognitive therapy in patients with anxiety disorders in secondary-care settings: A randomized controlled trial
    Ninomiya, Akira
    Sado, Mitsuhiro
    Park, Sunre
    Fujisawa, Daisuke
    Kosugi, Teppei
    Nakagawa, Atsuo
    Shirahase, Joichiro
    Mimura, Masaru
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2020, 74 (02) : 132 - 139
  • [45] The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: a randomized controlled trial
    van Aalderen, J. R.
    Donders, A. R. T.
    Giommi, F.
    Spinhoven, P.
    Barendregt, H. P.
    Speckens, A. E. M.
    PSYCHOLOGICAL MEDICINE, 2012, 42 (05) : 989 - 1001
  • [46] Mindfulness-based cognitive therapy for adherence of immunosuppressive treatment in liver transplant recipients: A randomized controlled trial
    Bulbuloglu, Semra
    Gunes, Huseyin
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2024, 20 (05)
  • [47] Mindfulness-Based Cognitive Therapy
    Heidenreich, Thomas
    Grober, Christoph
    Michalak, Johannes
    ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE, 2014, 43 (04): : 233 - 240
  • [48] Impact of mindfulness-based cognitive therapy on counseling self-efficacy: A randomized controlled crossover trial
    Chan, Sunny H. W.
    Yu, Calvin Kai-Ching
    Li, Alex W. O.
    PATIENT EDUCATION AND COUNSELING, 2021, 104 (02) : 360 - 368
  • [49] A RANDOMIZED CONTROLLED TRIAL OF MINDFULNESS-BASED COGNITIVE THERAPY FOR YOUTH LIVING WITH INFLAMMATORY BOWEL DISEASE AND DEPRESSION
    Ewais, T.
    Begun, J.
    Barclay, J.
    Tefay, M.
    Tremellen, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 149 - 150
  • [50] Impact of Mindfulness-Based Cognitive Therapy on Depressive Symptoms Reduction among Depressed Patients in Nigeria: A Randomized Controlled Trial
    Musa, Zulkiflu Argungu
    Soh, Kim Lam
    Mukhtar, Firdaus
    Soh, Kwong Yan
    Oladele, Tajudeen Olalekan
    Soh, Kim Geok
    ISSUES IN MENTAL HEALTH NURSING, 2021, 42 (07) : 667 - 675